Asbestos Upregulates Expression of the Urokinase-Type Plasminogen Activator Receptor on Mesothelial Cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 5, 1999, Pages 637-646

  Perkins, Raymond C ^a   Courtney Broaddus, V ^b   Shetty, Sreerama ^b   Hamilton, Sharon ^b   Idell, Steven ^b  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORYCTOLAGUS CUNICULUS;

CALCIUM DERIVATIVE; CALCIUM SILICATE; CELL SURFACE RECEPTOR; CHRYSOTILE; CROCIDOLITE; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR, UROKINASE RECEPTORS; RADIOACTIVE IODINE; SILICATE; UROKINASE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL MEMBRANE; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; FEMALE; GENETICS; GERMFREE ANIMAL; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MONOCYTE; PLEURA; RABBIT; UPREGULATION;

ANIMALS; ASBESTOS, CROCIDOLITE; ASBESTOS, SERPENTINE; CALCIUM COMPOUNDS; CELL MEMBRANE; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MONOCYTES; PLASMINOGEN ACTIVATORS; PLEURA; RABBITS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SILICATES; SPECIFIC PATHOGEN-FREE ORGANISMS; UP-REGULATION; URINARY PLASMINOGEN ACTIVATOR;

EID: 0033220573     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.5.3225     Document Type: Article

References (32)

1. Mossman, B. T., and J. B. L. Gee. 1989. Asbestos related diseases. N. Engl. J. Med. 320:1721-1730.
2. Becklake, M. R. 1976. Asbestos-related diseases of the lung and other organs: their epidemiology and implications for clinical practice. Am. Rev. Respir. Dis. 114:187-226.
3. Parkes, W. R. 1983. Occupational Lung Disorders, 2nd ed. Butterworths, London. 233-332.
4. Sahn, S. A., and V. B. Antony. 1984. Pathogenesis of pleural plaques: relationship of early cellular response and pathology. Am. Rev. Respir. Dis. 130:884-887.
5. Pass, H. I., and D. J. Mew. 1996. In vitro and in vivo studies of mesothelioma. J. Cell. Biochem. Suppl. 24:142-145.
6. Stephens, M., A. R. Gibbs, F. D. Pooley, and J. C. Wagner. 1987. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax 42:583-588.
7. Craighead, H. E., J. L. Abraham, A. Churg, F. H. Green, J. Kleinerman, P. C. Pratt, T. A. Seemayer, V. Vallyathan, and H. Weill. 1982. The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Arch. Pathol. Lab. Med. 106: 544-596.
8. Shetty, S., A. Kumar, A. R. Johnson, S. Pueblitz, and S. Idell. 1995. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am. J. Physiol. 268(Lung Cell. Mol. Physiol. 12):L972-L982.
9. Blasi, F., J. D. Vassalli, and K. Danø. 1987. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J. Cell. Biol. 104:801-804.
10. Yebra, M., G. C. N. Parry, S. Stro"mblad, N. Mackman, S. Rosenberg, B. M. Mueller, and D. A. Cheresh. 1996. Requirement of receptor-bound urokinase-type plasminogen activator for integrin ανβ5-directed cell migration. J. Biol. Chem. 271:29393-29399.
11. Mignatti, P., and D. B. Rifkin. 1996. Plasminogen activators and angiogenesis. Curr. Top. Microbiol. Immunol. 213:33-50.
12. Boylan, A. M., D. A. Sanan, D. Sheppard, and V. C. Broaddus. 1995. Vitronectin enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells via the integrin ανβ5. J. Clin. Invest. 96:1987-2001.
13. Lund, L. R., V. Ellis, E. Ronne, C. Pyke, and K. Dano. 1995. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549. Biochem. J. 310:345-352.
14. Yoshida, E., K. Tsuchiya, M. Sugiki, H. Sumi, H. Mihara, and M. Maruyama. 1996. Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators. Inflammation 20:319-322.
15. Haseqawa, T., L. Sorensen, M. Dohi, N. V. Rao, J. R. Hoidal, and B. C. Marshall. 1997. Induction of urokinase-type plasminogen activator receptor by IL-1β. Am. J. Respir. Cell Mol. Biol. 16:683-692.
16. Perkins, R. C., S. Vadhan-Raj, R. K. Scheule, R. Hamilton, and A. Holian. 1993. Effects of continuous high dose rhGM-CSF infusion on human monocyte activity. Am. J. Hematol. 43:279-285.
17. Shetty, S., A. Kumar, A. R. Johnson, S. Pueblitz, D. Holiday, G. Raghu, and S. Idell. 1996. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am. J. Respir. Cell Mol. Biol. 15:78-87.
18. Stoppelli, M. P., C. Tacchetti, M. V. Cubellis, A. Corti, V. J. Hearing, G. Cassani, E. Appella, and F. Blasi. 1986. Autocrine saturaton of pro-urokinase receptor on human A431 cells. Cell 45:675-684.
19. Reinartz, J., B. Schafer, R. Batrla, C. E. Klein, and M. D. Kramer. 1995. Plasmin abrogates ανβ5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin. Exp. Cell Res. 220:274-282.
20. Chomezynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA, and proteins from cell and tissue samples. Biotechniques 15:532-535.
21. Shetty, S., A. Kumar, and S. Idell. 1997. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mcsothelioma cells. Mol. Cell Biol. 17:1075-1083.
22. Idell, S., W. Girard, K. B. Koenig, J. McLarty, and D. S. Fair. 1991. Abnormalities of pathways of fibrin turnover in the human pleural space. Am. Rev. Respir. Dis. 144:187-194.
23. Gross, T. J., S. W. Cobb, D. C. Gruenet, and M. W. Peterson. 1993. Asbestos exposure increases human bronchial epithelial cell fibrinolytic activity. Am. J. Physiol. 264:L276-L283.
24. Lenz, S. P., F. H. Green, P. G. Murphy, M. Lee, and D. A. Hart. 1993. Expression of plasminogen activator and plasminogen activator inhibitor by rat mesothelioma induced by asbestos. Cancer Lett. 68:119-127.
25. Waltz, D. A., L. Z. Sailor, and H. A. Chapman. 1993. Cytokines induce urokinase-dependent adhesion of human myeloid cells: a regulatory role for plasminogen activator inhibitors. J. Clin. Invest. 91:1541-1552.
26. Waltz, D. A., and H. A. Chapman. 1994. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269:14746-14750.
27. Wei, Y., D. A. Waltz, N. Rao, R. J. Drummond, S. Rosenberg, and H. A. Chapman. 1994. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:32380-32388.
28. Wei, Y., M. Lukashev, D. I. Simon, S. C. Bodary, S. Rosenberg, M. V. Doyle, and H. A. Chapman. 1996. Regulation of integrin function by the urokinase function. Science 273:1551-1555.
29. Gyetko, M. R., C. C. Wilkinson, and R. G. Sitrin. 1993. Monocyte urokinase expression: modulation by interleukins. J. Leukoc. Biol. 53:598-601.
30. Griffith, D. E., E. J. Miller, L. D. Gray, S. Idell, and A. R. Johnson. 1994. Interleukin-1-mediated release of interleukin-8 by asbestos-stimulated human pleural mesothelial cells. Am. J. Respir. Cell Mol. Biol. 10:245-252.
31. Perkins, R. C., R. K. Scheule, and A. Holian. 1991. In vitro bioactivity of asbestos for the human alveolar macrophage and its modification by IgG. Am. J. Respir. Cell Mol. Biol. 4:532-537.
32. Kamp, D. W., M. Dunne, J. A. Anderson, S. A. Weitzman, and M. M. Dunn. 1990. Serum promotes asbestos-induced injury to human pulmonary epithelial cells. J. Lab. Clin. Med. 116:289-297.